Senegal

in page functions
Total population (2013) 14,133,280
Birth cohort (2013) 534,275
Surviving Infants (surviving to 1 year per year, 2013) 508,220
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 45/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 60/1000
World Bank Index, IDA (2012) 3.68
Gross Nation Income (per capita US$, 2012) 1,040
Co-financing status (2013) Intermediate
No. of districts/territories (2012) 76

GAVI support for Senegal

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Health system strengthening (HSS) $3,585,500 $3,585,500 $3,585,500 100%
HepB mono (NVS) $588,743 $588,743 $588,743 100%
Immunisation services support (ISS) $2,605,740 $2,605,740 $2,605,740 100%
Injection safety support (INS) $619,474 $619,474 $619,474 100%
Measles-Rubella (NVS) $4,751,997 $4,751,997 $4,751,997 100%
Meningitis A - campaign (NVS) $2,670,736 $2,670,736 $2,670,736 100%
Meningitis A - operational costs (OPC) $2,567,107 $2,567,107 $2,567,107 100%
MR - Operational costs (OPC) $4,158,500 $4,158,500 $4,158,500 100%
Penta (NVS) $40,197,365 $42,961,865 $39,139,309 97%
Pneumo (NVS) $9,157,275 $22,689,275 $7,779,513 85%
Vaccine Introduction Grant $914,000 $914,000 $914,000 100%
Total $71,816,437 $88,112,937 $69,380,620

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
92%

**
DTP3 - Official country estimates (2012) 70%
M:F sex ratio at birth (2013) 1.04
Household survey: DTP3 coverage for male (2013) 88.90%
Household survey: DTP3 coverage for female (2013) 88.10%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2012)
% districts achieving < 50% DTP3 coverage (2012)
MCV WHO/UNICEF estimates (2012) 84%
Polio WHO/UNICEF estimates (2012) 89%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$14,450,321 $54,930,297

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

05 November 2013

senegal2.jpg

GAVI Alliance welcomes introduction of two life-saving vaccines in Senegal

Senegalese children to benefit from pneumococcal and measles-rubella vaccines .

22 October 2013

UNICEF Cambodia

GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella

More than four million children will receive the measles-rubella vaccine over the next three months.

close icon

modal window here